These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of neuroleptic drugs on endogenous opioid peptides in the rat. Höllt V Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450 [No Abstract] [Full Text] [Related]
5. [Neuroleptics and serotonin]. Hery F; Hamon M Encephale; 1993; 19(5):525-32. PubMed ID: 7905821 [TBL] [Abstract][Full Text] [Related]
6. The complexity of dopamine receptors and psychopharmacotherapy in children. Guérin P; Barthélémy C; Garreau B; Héraut J; Muh JP; Lelord G Acta Paedopsychiatr; 1993; 56(2):139-51. PubMed ID: 7510920 [TBL] [Abstract][Full Text] [Related]
7. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity. Scatton B J Pharmacol Exp Ther; 1982 Jan; 220(1):197-202. PubMed ID: 6118430 [No Abstract] [Full Text] [Related]
8. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain. Scatton B Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783 [No Abstract] [Full Text] [Related]
9. Neuroleptic drugs and their action on different neuronal pathways. Ungerstedt U; Herrera-Marschitz M; Forster C J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478 [TBL] [Abstract][Full Text] [Related]
11. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia]. Lideman RR; Zlobina GP; Mukhin AG Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337 [No Abstract] [Full Text] [Related]
12. [Neurotensin, dopamine and mode of action of neuroleptics]. Tassin JP Encephale; 1989; 15(5):465-70. PubMed ID: 2574102 [TBL] [Abstract][Full Text] [Related]
14. [Role of dopamine receptors in the mechanism of action of neuroleptics]. Lavretskaia EF; Kats MM; Baldenkov GN Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):431-5. PubMed ID: 2859724 [TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Sokoloff P; Giros B; Martres MP; Bouthenet ML; Schwartz JC Nature; 1990 Sep; 347(6289):146-51. PubMed ID: 1975644 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes. Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690 [TBL] [Abstract][Full Text] [Related]
17. Integrating the neurobiology of schizophrenia. Preface. Abi-Dargham A; Guillin O Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855 [No Abstract] [Full Text] [Related]
18. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390. Hess EJ; Creese I Psychopharmacol Bull; 1986; 22(3):605-12. PubMed ID: 2879304 [No Abstract] [Full Text] [Related]
19. [Biochemical mechanism of action of neuroleptics (author's transl)]. Scatton B Encephale; 1981; 7(3):201-14. PubMed ID: 6116590 [TBL] [Abstract][Full Text] [Related]
20. [The effect of rudotel on the synaptic activity of dopaminergic neurons]. Podgornaia EK; Galkina OV; Il'iuchenok RIu; Poliakov OV Eksp Klin Farmakol; 1998; 61(4):10-1. PubMed ID: 9783098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]